Spero Therapeutics Announces Positive Topline Results from its P

做多

CBOE S&P 500 Buffer Protect Index Balanc (CBOE:SPRO)

CBOE:SPRO CBOE S&P 500 Buffer Protect Index Balanc

beyondta

SPRO: Spero Therapeutics, Inc.
2020-09-08 07:30:10
Spero Therapeutics Announces Positive Topline Results from its Phase 3 ADAPT-PO Clinical Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。